Use of folic acid casei medium reveals trimethoprim susceptibility of Lactobacillus species.
D000890:Anti-Infective Agents / Q000494:pharmacology; D003470:Culture Media / Q000737:chemistry*; D003853:Deoxyribonucleosides / Q000378:metabolism; D024881:Drug Resistance, Bacterial / Q000235:genetics; D005492:Folic Acid / Q000378:metabolism; D005493:Folic Acid Antagonists / Q000494:pharmacology; D007778:Lactobacillus / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development; D008826:Microbial Sensitivity Tests / Q000379:methods*; D013939:Thymidine Phosphorylase / Q000378:metabolism; D013941:Thymine / Q000378:metabolism; D014295:Trimethoprim / Q000494:pharmacology*
D000890:Anti-Infective Agents; D003470:Culture Media; D003853:Deoxyribonucleosides; D005493:Folic Acid Antagonists; D005492:Folic Acid; D014295:Trimethoprim; D013939:Thymidine Phosphorylase; D013941:Thymine